Document Detail

Synergistic effects of vasopressin plus epinephrine during cardiopulmonary resuscitation.
MedLine Citation:
PMID:  10203408     Owner:  NLM     Status:  MEDLINE    
Both epinephrine (Epi) and vasopressin (VP) increase coronary perfusion pressure (CPP) when administered during cardiac arrest. Given their different mechanisms of action we tested the hypothesis that during cardiopulmonary resuscitation (CPR) a combination of VP plus Epi would be superior to either agent alone. Epi(40 microg/kg), VP(0.3 U/kg) and the combination of both agents were assessed in a porcine model of ventricular fibrillation (VF). Maximum CPP (diastolic aortic-right atrial pressures) during CPR was similar among the groups but the time course of action was different in each group: with Epi + VP the increase in CPP was significantly more rapid than with VP alone whereas the CPP remained significantly higher for a longer periods of time with VP or VP + Epi versus Epi alone. Left ventricular blood flow (ml/min per g) determined during CPR two min after drug administration was similar between groups: Epi 1.06 +/- 0.16; VP 0.82 +/- 0.26; Epi + VP 0.83 +/- 0.14 (P = N.S.). Post drug administration. 2 min, cerebral blood flow (ml/min per g) in the VP group (0.76 +/- 0.15) was more than two times higher compared with Epi alone (Epi:0.30 +/- 0.08, P < 0.01 versus VP) and Epi plus VP (Epi + VP:0.23 +/- 0.03, P < 0.01 versus VP). We conclude that combination of VP + Epi during cardiac arrest results in a more rapid rise in CPP when compared with VP alone and a more sustained elevation in CPP than observed with Epi alone. Thus, the synergistic effects of these two potent vasopressor agents may be of benefit during CPR.
K A Mulligan; S H McKnite; K H Lindner; P J Lindstrom; B Detloff; K G Lurie
Related Documents :
8005128 - Effects of ramipril on the neurohormonal response to exercise in patients with mild or ...
23803298 - Semantic memory functional mri and cognitive function after exercise intervention in mi...
18185948 - Serum markers of systemic right ventricular function and exercise performance.
11568308 - Reduced oxygen tension increases atrial natriuretic peptide release from atrial cardioc...
9268958 - Temporal inhomogeneity in brachial artery blood flow during forearm exercise.
9032488 - Nasal mucociliary transport is impaired at altitude.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Resuscitation     Volume:  35     ISSN:  0300-9572     ISO Abbreviation:  Resuscitation     Publication Date:  1997 Nov 
Date Detail:
Created Date:  1999-04-27     Completed Date:  1999-04-27     Revised Date:  2009-08-25    
Medline Journal Info:
Nlm Unique ID:  0332173     Medline TA:  Resuscitation     Country:  IRELAND    
Other Details:
Languages:  eng     Pagination:  265-71     Citation Subset:  IM    
Cardiac Arrhythmia Center, University of Minnesota, Minneapolis 55455, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic Agonists / administration & dosage,  therapeutic use*
Aorta / drug effects
Atrial Function, Right / drug effects
Blood Pressure / drug effects
Cardiac Output / drug effects
Cardiopulmonary Resuscitation*
Cerebrovascular Circulation / drug effects
Drug Combinations
Drug Synergism
Epinephrine / administration & dosage,  therapeutic use*
Heart Arrest / drug therapy,  therapy
Heart Atria / drug effects
Random Allocation
Vasoconstrictor Agents / administration & dosage,  therapeutic use*
Vasopressins / administration & dosage,  therapeutic use*
Ventricular Fibrillation / drug therapy,  therapy
Ventricular Function, Left / drug effects
Reg. No./Substance:
0/Adrenergic Agonists; 0/Drug Combinations; 0/Vasoconstrictor Agents; 11000-17-2/Vasopressins; 51-43-4/Epinephrine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Force distribution across the heel of the hand during simulated manual chest compression.
Next Document:  Clinical validation of a new immunoradiometric assay for intact human osteocalcin.